European Heart Journal-Quality of Care and Clinical Outcomes

Article	Citations
Ambulance drive-thru troponin, ready to go?	111
Letter to the editor in response to Kobo et al. 2022	57
Implementing rapid algorithms for high-sensitivity troponin—economic benefits and caveat emptor	55
Beyond biomarkers: the relevance of supporting evidence in the diagnosis of periprocedural myocardial infarction	47
Key priorities for the implementation of the 2023 ESC Guidelines for the management of acute coronary syndromes in low-resource settings	45
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied	42
Evolving perspectives in personalized cardiovascular care	37
Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis	36
Secundum atrial septal defect closure in adults in the UK	35
Hypertrophic cardiomyopathy management: a systematic review of the clinical practice guidelines and recommendations	33
Impact of residual angina on long-term clinical outcomes after percutaneous coronary intervention or coronary artery bypass graft for complex coronary artery disease	32
Long-term aspirin adherence following myocardial infarction and risk of cardiovascular events	30
Alcoholic cardiomyopathy-attributed mortality in Europe, 2012–20	30
Applicability of guideline-informing lipid-lowering clinical trials to contemporary real-world patients with atherosclerotic cardiovascular disease	28
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiomyopathies in low-resource settings	27
The cost-effectiveness of semaglutide in reducing cardiovascular risk among people with overweight and obesity and existing cardiovascular disease, but without diabetes	27
Association between delayed statin initiation after high LDL-cholesterol detection and cardiovascular risk in general health screening examinees	23
Influence of multiple risk factor control level on cardiovascular outcomes in hypertensive patients	23
Fifteen-year secular changes in the care and outcomes of patients with out-of-hospital cardiac arrest in Japan: a nationwide, population-based study	23
Cost-effectiveness of population screening for aortic stenosis	23
Mitral valve prolapse: incidence and prognosis related to serum levels of sex hormone-binding globulin	21
Mapping the modern heart failure epidemic: growing burden, root causes, and widening inequalities	20
Economic burden of cardiovascular disease in the United Kingdom	19
The Rising Burden of Enterococcal Endocarditis: Insights From Contemporary European Data	19
Correction to: Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study	19

Rapid Assessment and Treatment In Decompensated Aortic Stenosis (ASTRID-AS study)- A pilot study	18
Impact of low physical activity on cardiovascular disease across regions and demographic groups: insights from the Global Burden of Disease Study	18
Prognostic impact of anaemia in patients undergoing aortic valve replacement: a nationwide study	17
Erratum to: Economic burden of patients living with heart disease in the last years of life in Australia: a retrospective analysis using linked data	17
Cost-effectiveness of atrial fibrillation screening programmes across European nations	17
Cancer and the risk of perioperative arterial ischaemic events	17
Post-discharge pharmacotherapy in people with atrial fibrillation hospitalized for acute myocardial infarction: an Australian cohort study 2018–22	17
Letter to the editor in response to Sengupta et al. (2022)	16
Risk-standardized mortality metric to monitor hospital performance for chest pain presentations	16
Estimated annual healthcare costs after acute pulmonary embolism: results from a prospective multicentre cohort study	16
The beginning of wisdom is the definition of terms: counting heart failure hospitalizations	16
Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	15
LDL-cholesterol lowering, the earlier the better: lessons from the real world	15
Association of cumulative health status with subsequent mortality in patients with acute heart failure	15
Greenness exposure and mortality risk in a cardio-oncologic population	14
Heart failure with preserved ejection fraction management: a systematic review of clinical practice guidelines and recommendations	14
Sex-based differences in heart failure development during STEMI hospitalization	14
Standardized and hierarchically classified heart failure and complementary disease monitoring outcome measures: European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	14
Contemporary trends in incident ischaemic stroke, intracranial haemorrhage, and mortality in individuals with atrial fibrillation	14
Machine learning for prediction of all-cause mortality after transcatheter aortic valve implantation	14
A decade of follow-up: atrial fibrillation, pulmonary pressure, and the progression of tricuspid regurgitation	13
The semaglutide paradox in non-overweight diabetes: a benefit without explanation	13
Clinical Outcomes in Hospitalized Patients with Cancer and New versus Preexistent Atrial Fibrillation	13
Periprocedural myocardial infarction after coronary artery bypass grafting: defining what matters	13
Transcatheter vs. surgical mitral valve interventions in patients with prior coronary artery bypass grafting	12
Hospital admissions in the last year of life of patients with heart failure	12
Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort study	12
Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry	12
Safety of AF ablation–its evolution over time and lessons from down under	12
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly	12
National health expenditure per capita is associated with CRT implantation practice: findings from the ESC CRT Survey II with 11 088 patients	11
Association between Early Oral β-Blocker Therapy and Risk for In-Hospital Major Bleeding after Percutaneous Coronary Intervention for Acute Coronary Syndrome: Findings from CCC-ACS Project	11
RNA-targeted therapeutics in arterial hypertension	11
Addressing the impact of social determinants of health in congenital heart disease	11
Bacteraemia and infective endocarditis following left-sided heart valve surgery	11
Clinical outcomes following invasive cardiovascular interventions in frail populations: a systematic review and meta-analysis	11
Suspected Non-ST-elevation acute coronary syndrome meeting rapid rule-out criteria: resource utilization, diagnostic yield, and clinical outcomes of hospital admission	11
Treating the patient, not just the valve: can we predict which transcatheter aortic valve implantation patients truly benefit?	11
Quality of life and societal costs in patients with dilated cardiomyopathy	11
Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries	11
POAF after CABG: early risk, landmark bias, and the case for selective anticoagulation	11
Global, regional, and national burden of atrial fibrillation/flutter related to metabolic risks over three decades: estimates from the global burden of disease study 2019	10
Ischemic Cerebrovascular Events Post Atrial Fibrillation Catheter Ablation: A Descriptive Report on the ITHACA Database	10
Current epidemiology and management of acute heart failure: the multicenter prospective OFICA2 cohort	10
Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	10
Elementary school performance of children with congenital heart disease: a Danish nationwide cohort study	10
Association of baseline and changes in health-related quality of life with mortality following myocardial infarction: multicentre longitudinal linked cohort study	10
Trends and projections of heart failure among adolescents and young adults: an in-depth analysis for the Global Burden of Disease Study 2021	10
Reperfusion strategies on the clinical outcomes of ST-elevation myocardial infarction patients over 80 years old in China	9
Incidence, predictors, and prognostic impact of rehospitalization after transcatheter aortic valve implantation	9

Implantable cardioverter defibrillators in heart failure with reduced ejection fraction after myocardial infarction: the need for contemporary evidence	9
Optimizing anticoagulant therapy: is pharmacist-led intervention the best	9
Atrial Fibrillation Ablation in Hypertrophic Obstructive Cardiomyopathy: Are We There Yet?	9
Impact of COVID-19 pandemic on the incidence and prevalence of postural orthostatic tachycardia syndrome	9
Non-invasive physiological assessment of intermediate coronary stenoses from plain angiography through artificial intelligence: the STARFLOW system	9
Predictive factors of surgical repair technique in infants with coarctation of the aorta	9
Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?	9
The less lonely and the more satisfied you are, the merrier is … the heart!	9
Cohort profile: the prospective cohort study on the incidence of metabolic diseases and risk factors in Shunde, China (Speed-Shunde cohort)	8
Comprehensive risk factor management for hypertensive patients	8
Diagnostic accuracy, clinical characteristics, and prognostic differences of patients with acute myocarditis according to inclusion criteria	8
Temporal trends in loss of expected lifetime associated with cardiovascular complications following newly diagnosed atrial fibrillation: a Danish nationwide cohort study from 2000 to 2022	8
Renin–angiotensin system inhibition and in-hospital mortality in acute coronary syndrome patients with advanced renal dysfunction: findings from CCC-ACS project and a nationwide electronic health reco	8
Seasonal influenza vaccine uptake among patients with cardiovascular disease in Denmark, 2017–2019	8
One year healthcare consumption prior to sudden cardiac death	8
Current management of transition and multidisciplinary care of patients with inherited and rare cardiomyopathies in Europe: results of the European Reference Network for rare and low prevalence comple	8
Disparities in ST-elevation myocardial infarction diagnosis and management among patients with mental health conditions	8
Trends in atrial fibrillation-related mortality in Europe, 2008–2019	8
Trends and risk factors analysis of aortic aneurysm mortality in China over thirty years: based on the global burden of disease 2019 data	8
Quality of care and long-term survival after ST-elevation myocardial infarction in adults with cancer	8
Adapting predictive risk models and preventive strategies across different socio-economic regions to reduce global cardiovascular burden	8
Heart failure in an ageing world: closing the evidence-equity gap	8
Real-world evidence and quality improvement in heart failure and cardiomyopathies	7
Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study	7
Rigour of development of European Society of Cardiology, American College of Cardiology and American Heart Association guidelines over a 12-year period (2013–2024): a systematic review of guidelines	7
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings	7
Regional disparities in heart transplant mortality in the USA	7
Assessing the health impact of low seafood omega-3 intake on ischaemic heart disease: trends, demographic disparities, and forecasts	7
Association of atrial fibrillation with survival in patients with low-flow low-gradient aortic stenosis with preserved ejection fraction undergoing TAVI	7
Tricuspid transcatheter edge-to-edge repair for tricuspid valve regurgitation: a sex-based real-world analysis from the TRI-SPA registry	7
Remnant cholesterol and risk of premature mortality: an analysis from a nationwide prospective cohort study	7
Cost-effectiveness of catheter-based radiofrequency renal denervation for the treatment of uncontrolled hypertension: an analysis for the UK based on recent clinical evidence	7
Comment on “Association of Menopausal Hormone Therapy with Incident Cardiovascular Disease in Women Veterans”	6
Global, regional, and national burden of pulmonary arterial hypertension and related heart failure from 1990 to 2021, with predictions to 2050: insights from the global burden of disease study 2021	6
Unravelling the gaps in diagnosis and management of arrhythmogenic cardiomyopathy	6
The patient journey in chronic coronary syndromes with/without obstructive coronary arteries	6
Relationship between hospital mortality and readmission rates after transcatheter aortic valve replacement	6
The burden of atrial fibrillation related to metabolic risks: different countries and territories, yet the same challenges	6
Existing health disparities in congenital heart disease: the path forward to achieving health equity—A scientific statement of the European Association of Preventive Cardiology of the ESC	6
Machine learning-based identification of risk-factor signatures for undiagnosed atrial fibrillation in primary prevention and post-stroke in clinical practice	6
Myocarditis in 2025: ESC Guidelines advance the field and highlight the opportunity for evidence to follow	6
Impact of the method of calculating 30-day readmission rate after hospitalization for heart failure. Data from the VancOuver CoastAL Acute Heart Failure (VOCAL-AHF) registry	6
Inequality across the cardiac rehabilitation trajectory in Denmark: investigating key sociodemographic and health-related drivers	6
Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990–2019	6
Estimating the impact of implementing an integrated care management approach with Atrial fibrillation Better Care (ABC) pathway for patients with atrial fibrillation in England from 2020 to 2040	6
Global burden of heart failure in older adults: trends, socioeconomic inequalities, and future projections from 1990 to 2035	5
Impact of intravascular ultrasound for coronary bifurcations treated with last-generation stents: insights from the ULTRA-BIFURCAT registry	5
Economic evaluation of the Liverpool heart failure virtual ward model	5
Association of socioeconomic status in the incidence, quality-of-care metrics, and outcomes for patients with cardiogenic shock in a pre-hospital setting	5
A systematic assessment of the characteristics of randomized controlled trials cited by acute coronary syndrome clinical practice guidelines	5
The influence of social deprivation in infective endocarditis: a retrospective observational study of the London endocarditis research network	5
Health economic evaluation of nation-wide screening programmes for atrial fibrillation in the Netherlands	5
Change in prevalence of ATTR variants in Italy: results from a national survey	5
Prognostic role of myocardial storage, hypertrophy and inflammation/fibrosis in Fabry Cardiomyopathy: a new predictive score including T1 values	5
The assessment and management of patients with type 2 myocardial infarction: an international Delphi study	5
Implications of structural right ventricular involvement in patients with hypertrophic cardiomyopathy	5
Correspondence to the European Heart Journal—Quality of Care and Clinical Outcomes in response to the paper by Thygesen et al. (2021)	5
Driving restrictions following defibrillator implantation: a nationwide register-linked survey study on the impact on employment, daily living, and driving behaviour	5
Priority measures for implementation: an ESC pilot linking guidelines to practice	5
Non-steroidal anti-inflammatory drugs and oral anticoagulants in atrial fibrillation: common practice, avoidable harm	5
Bridging the gaps in cardiac rehabilitation: from identifying inequalities to delivering fair, person-centred care	5
Psoriasis and risk of new-onset degenerative valvular heart disease: a prospective cohort study	5
The Italian Fabry Disease Cardiovascular Registry (IFDCR)	5
Meta-analysis of the Placebo and Nocebo effects associated with Placebo treatment in randomized trials of lipid-lowering therapies	5
Trends in ST-elevation myocardial infarction hospitalization among young adults: a binational analysis	5
Association between quality of care indicators and clinical outcomes in patients undergoing transcatheter aortic valve implantation: insights from SWEDEHEART	5
Feasibility of coronary access after transcatheter aortic valve implantation (TAVI): a systematic review and meta-analysis of observational studies	4
Cardiovascular disease burden due to productivity losses in European Society of Cardiology countries	4
Correspondence to the European Heart Journal – Quality of Care and Clinical Outcomes in response to the paper by Warming et al. (2022): Atrial fibrillation and chronic obstructive pulmonary disease: d	4
Should we routinely measure patient quality of life after acute coronary syndrome?	4
Transradial versus transfemoral approach for percutaneous coronary intervention in patients with ST-elevation myocardial infarction complicated by cardiogenic shock: a systematic review and meta-analy	4
Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019	4
Primary prevention ICD: essential safeguard or personalized selectivity?	4
A nationwide study of the economic burden of obstructive hypertrophic cardiomyopathy in France	4
Trends in risk factors among young patients with acute myocardial infarction: a nationwide cohort study	4
Atrial fibrillation screening and clinical outcomes: a meta-analysis of randomized controlled trials	4
Psychiatric morbidity and work participation in patients with congenital ventricular septal defects: a case-controlled study	4
Heart failure clinical registries vs. registering the reality of heart failure	4
When the pain persists: redefining quality of care in women with INOCA	4
Association of healthy sleep pattern with risk of recurrent cardiovascular events among patients with coronary heart disease	4

Aortic regurgitation management: a systematic review of clinical practice guidelines and recommendations	4
Inclusion and reporting by age, sex, and ethnicity in clinical studies of high-risk medical devices approved in the European Union	4
Incidence of myocardial infarction, heart failure, and cardiovascular mortality in patients with peripheral artery disease: trends between 1997 and 2016	4
Cardiovascular outcomes and safety of semaglutide in non-overweight populations with type 2 diabetes: a comparison with dipeptidyl peptidase 4 inhibitors	4
Marathons for women and sprints for men: shall we all run together?	4
Editorial: Beyond obesity: metabolic status as key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography	4
Mechanical circulatory support devices vs. standard medical therapy for treatment of myocardial infarction complicated by cardiogenic shock: a network meta-analysis	4
The first International Consortium for Health Outcomes Measurement (ICHOM) standard dataset for reporting outcomes in heart valve disease: moving from device- to patient- centered outcomes	4
COP27 Climate Change Conference: urgent action needed for Africa and the world	4
De-frailing intervention for hospitalized cardiovascular patients in the TARGET-EFT randomized clinical trial	4
Integrating cultural background into the psychological and social prevention of cardiovascular diseases	4
Cardiopulmonary long-term effects 30 months after severe COVID-19 infection	4
Correction to: The evolving landscape of atrial fibrillation: diagnosis and therapy	4
Representativeness in randomised clinical trials supporting acute coronary syndrome guidelines	4
Catheter ablation as an adjunctive therapy to ICD implantation in Brugada Syndrome	4
Update on long-term cardiovascular risk after pre-eclampsia: a systematic review and meta-analysis	4
Long-term cardiovascular disease after pre-eclampsia: time to move from epidemiology to action	4
Development and validation of multivariable risk adjustment models for return of spontaneous circulation and survival to hospital discharge following out-of-hospital cardiac arrest in England	3
Association between cancer, CHA2DS2VASc risk, and in-hospital ischaemic stroke in patients hospitalized for atrial fibrillation	3
GLP-1 receptor agonists and clinical outcomes in patients with type 2 diabetes undergoing transcatheter aortic valve implantation	3
An early accumulation of serum uric acid confers more risk of heart failure: a 10-year prospective cohort study	3
The impact of atrial fibrillation on prognosis in aortic stenosis	3
Comparison of mitral valve repair vs. replacement for mitral valve regurgitation	3
Letter to the Editor in Response to Sengupta et al. (2022)	3
Increased medical contact: a first step for near-term prevention of sudden cardiac death?	3
The evolving landscape of atrial fibrillation: diagnosis and therapy	3
Impact of glomerular filtration rate estimation formulas on MECKI score performance and prognostic accuracy in heart failure: the MECKI-RENAL study	3
Acute coronary occlusion with vs. without ST elevation: impact on procedural outcomes and long-term all-cause mortality	3
A cost-effectiveness analysis of hypertrophic cardiomyopathy sudden cardiac death risk algorithms for implantable cardioverter defibrillator decision-making	3
Corrigendum to: Comparison of HAS-BLED and ORBIT bleeding risk scores in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: a report from the ESC-EHRA EORP-AF Gene	3
The controversy between atrial fibrillation subtypes and worsening heart failure	3
Predicting new-onset heart failure hospitalization of patients with atrial fibrillation: development and external validations of a risk score	3
Bleeding risk using non-steroidal anti-inflammatory drugs in anticoagulated patients with atrial fibrillation: a nationwide cohort study	3
Atrial fibrillation—lost lifetimes and the urgent need for outcome-driven management	3
Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)	3
Risk of incident cardiovascular disease among patients with gastrointestinal disorder: a prospective cohort study of 330 751 individuals	3
Vaccines and myocardial injury in patients hospitalized for COVID-19 infection: the CardioCOVID-Gemelli study	3
Clinical and genetic diagnosis of familial hypercholesterolaemia in patients undergoing coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study	3
Association of menopausal hormone therapy with incident cardiovascular disease in women veterans	3
Socioeconomic variations determine the clinical presentation, aetiology, and outcome of infective endocarditis: a prospective cohort study from the ESC-EORP EURO-ENDO (European Infective Endocarditis)	3
β-blocker adherence among patients with congenital long QT syndrome: a nationwide study	3
Heart valve disease in the modern era: a call for holistic, long-term management	3
Preparation for cardiac procedures: a cross-sectional study identifying gaps between outpatients’ views and experiences of patient-centred care	3
Temporal trends in disease-specific causes of cardiovascular mortality amongst patients with cancer in the USA between 1999 and 2019	3
A hidden problem: peripheral artery disease in women	3
The association of temporal sequence in atrial fibrillation and chronic obstructive pulmonary disease diagnosis and mortality risk: Reply	3
Corrigendum to: Cohort profile: Evaluation of the Methods and Management of Acute Coronary Events (EMMACE) longitudinal cohort	3
Prognostic value of weight loss in hospitalized patients with heart failure	3
Reduced access to primary care for immigrants increases cardiovascular complications and hospital admissions: the importance of information and education	3
Educational inequalities in cardiovascular diseases and their mediating factors across different generations: a prospective cohort study	3
Quality counts: revisiting anticoagulation after mechanical aortic valve replacement in patients with atrial fibrillation	2
European Society of Cardiology quality indicators for the care and outcomes of adults undergoing transcatheter aortic valve implantation	2
Longitudinal risk of death, hospitalizations for atrial fibrillation, and cardiovascular events following catheter ablation of atrial fibrillation: a cohort study	2
Adherence to perindopril/amlodipine/atorvastatin combination according to the administration strategy	2
Specialist services for cardiomyopathy: quality care requires diagnostic accuracy	2
Using SCORE2 with a risk chart or online calculator: impact on model performance, treatment eligibility, and cardiovascular disease prevention	2
High risk of rehospitalization within 1 year following a pulmonary embolism—insights from the Danish nationwide registries from 2000–2020	2
Letter to the editor in response to Kobo et al. (2022)	2
Temporal trend analysis of rheumatic heart disease burden in high-income countries between 1990 and 2019	2
Corrigendum to: Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)	2
Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries	2
Association of acute increases in serum creatinine with subsequent outcomes in patients with type 2 diabetes mellitus treated with sodium–glucose cotransporter 2 inhibitor or dipeptidyl peptidase-4 in	2
Cost-effectiveness of intravascular ultrasound-guided percutaneous intervention in patients with acute coronary syndromes: a UK perspective	2
Clinicoeconomic burden among heart failure patients with severely reduced ejection fraction after hospital admission: HF-RESTORE	2
Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials	2
Global, regional, and national burden of heart failure and its risk factors between 1990 and 2021 and projections to 2050: an analysis of the global burden of disease study	2
Beyond obesity: metabolic status as a key driver for cardiovascular outcomes in patients undergoing invasive coronary angiography	2
Aiming at a better guidance in the post-pulmonary embolism syndrome management: is the gap fully filled out?	2
The cardiovascular disease burden attributable to kidney dysfunction from 1990 to 2021: an age–period–cohort analysis of the Global Burden of Disease study	2
Does Down syndrome influence the outcomes of congenital cardiac surgery? A systematic review and meta-analysis	2
Sharing the load to improve clinical outcomes in cardiogenic shock treated using venoarterial ECMO	2
Need for home care or nursing home admission after myocardial infarction complicated by cardiogenic shock and/or out-of-hospital cardiac arrest	2
Substance use disorder and heart transplantation: no independent risk, but still a reason for caution	2
Kidney function and the comparative effectiveness and safety of direct oral anticoagulants vs. warfarin in adults with atrial fibrillation: a multicenter observational study	2
Key priorities for the implementation of the 2023 ESC Guidelines for the management of endocarditis in low-resource settings	2
Trends in treatment and outcomes of atrial fibrillation during 2007–17 in Finland	2
The quality of care and long-term mortality of out of hospital cardiac arrest survivors after acute myocardial infarction: a nationwide cohort study	2
Transcatheter aortic valve implantation: the fountain of second youth?	2
Impact of biomarker type on periprocedural myocardial infarction in patients undergoing elective PCI	2
Association of socioeconomic status with 30-day survival following out-of-hospital cardiac arrest in Scotland, 2011–2020	2
Differential associations of cardiorenal-inflammatory markers with cardiac and cancer mortality in cancer survivors	2
Uptitration of statin therapy in women and men: a population-based cohort study	2
Temporal trends of mortality in patients with infective endocarditis: a nationwide study	2
The European Heart Journal. Quality of Care and Clinical Outcome in the years to come: a salutation from the incoming Editor-in-Chief	2
Relationship between remnant cholesterol and risk of heart failure in participants with diabetes mellitus: Reply	2
Assessment of the safety and efficacy of catheter ablation for atrial fibrillation in very elderly patients: insight from the national prospective registry study	2
The cost-effectiveness of rivaroxaban with or without aspirin in the COMPASS trial	2